US Stock MarketDetailed Quotes

NKGN NKGEN BIOTECH

Watchlist
  • 1.670
  • +0.100+6.37%
Close May 31 16:00 ET
  • 1.700
  • +0.030+1.80%
Post 19:59 ET
41.56MMarket Cap-440P/E (TTM)

NKGEN BIOTECH Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
-81.92%77K
0
3K
426K
Operating revenue
--0
--0
--0
--0
--0
-81.92%77K
--0
--3K
--426K
Cost of revenue
0
0
0
-40.00%18K
15K
0
30K
Gross profit
0
0
0
-85.10%59K
-15K
3K
396K
Operating expense
12.11%7.62M
21.88%29.75M
51.03%9.43M
15.15%6.9M
6.8M
9.65%24.41M
6.25M
6M
22.26M
Selling and administrative expenses
37.07%4.39M
83.81%14.08M
147.50%5.34M
58.70%2.97M
--3.2M
0.98%7.66M
--2.16M
--1.87M
--7.59M
-General and administrative expense
37.07%4.39M
83.81%14.08M
147.50%5.34M
58.70%2.97M
--3.2M
0.98%7.66M
--2.16M
--1.87M
--7.59M
Research and development costs
-10.09%3.24M
-6.44%15.67M
0.10%4.09M
-4.66%3.93M
--3.6M
14.14%16.75M
--4.09M
--4.12M
--14.67M
Operating profit
-12.11%-7.62M
-22.18%-29.75M
-50.67%-9.43M
-15.20%-6.9M
-6.8M
-11.37%-24.35M
-6.26M
-5.99M
-21.86M
Net non-operating interest income expense
-5,188.24%-1.8M
67.69%-745K
28.90%-438K
66.82%-211K
-34K
-75.36%-2.31M
-616K
-636K
-1.32M
Non-operating interest expense
3,044.12%1.07M
-67.69%745K
-28.90%438K
-66.82%211K
--34K
75.36%2.31M
--616K
--636K
--1.32M
Total other finance cost
--729K
----
----
----
----
----
----
----
----
Other net income (expense)
370.94%4.04M
-55,116.84%-52.46M
-36,406.15%-23.73M
-39,996.92%-26.06M
-1.49M
-13.10%-95K
-65K
-65K
-84K
Gain on sale of security
--4.53M
---48.2M
---23.73M
---24.48M
----
----
----
----
----
Special income (charges)
----
---3.33M
--0
---3.33M
----
--0
--0
--0
----
-Less:Restructuring and merger&acquisition
----
--3.33M
--0
--3.33M
----
--0
--0
--0
----
Other non- operating income (expenses)
66.64%-497K
-871.58%-923K
--0
2,778.46%1.74M
---1.49M
-13.10%-95K
---65K
---65K
---84K
Income before tax
35.33%-5.38M
-210.12%-82.95M
-384.07%-33.6M
-395.70%-33.18M
-8.32M
-14.99%-26.75M
-6.94M
-6.69M
-23.26M
Income tax
0.00%7K
0.00%7K
0
40.00%7K
7K
0
5K
Net income
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-8.32M
-15.00%-26.75M
-6.95M
-6.69M
-23.27M
Net income continuous Operations
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
---8.32M
-15.00%-26.75M
---6.95M
---6.69M
---23.27M
Minority interest income
Net income attributable to the parent company
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-8.32M
-15.00%-26.75M
-6.95M
-6.69M
-23.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-8.32M
-15.00%-26.75M
-6.95M
-6.69M
-23.27M
Basic earnings per share
2.06%-0.25
-555.62%-5.38
-688.33%-1.68
-1,108.06%-2.48
-0.2553
-15.00%-0.8206
-0.2131
-0.2053
-0.7136
Diluted earnings per share
2.06%-0.25
-555.62%-5.38
-688.33%-1.68
-1,108.06%-2.48
-0.2553
-15.00%-0.8206
-0.2131
-0.2053
-0.7136
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(FY)Dec 31, 2021
Total revenue 00000-81.92%77K03K426K
Operating revenue --0--0--0--0--0-81.92%77K--0--3K--426K
Cost of revenue 000-40.00%18K15K030K
Gross profit 000-85.10%59K-15K3K396K
Operating expense 12.11%7.62M21.88%29.75M51.03%9.43M15.15%6.9M6.8M9.65%24.41M6.25M6M22.26M
Selling and administrative expenses 37.07%4.39M83.81%14.08M147.50%5.34M58.70%2.97M--3.2M0.98%7.66M--2.16M--1.87M--7.59M
-General and administrative expense 37.07%4.39M83.81%14.08M147.50%5.34M58.70%2.97M--3.2M0.98%7.66M--2.16M--1.87M--7.59M
Research and development costs -10.09%3.24M-6.44%15.67M0.10%4.09M-4.66%3.93M--3.6M14.14%16.75M--4.09M--4.12M--14.67M
Operating profit -12.11%-7.62M-22.18%-29.75M-50.67%-9.43M-15.20%-6.9M-6.8M-11.37%-24.35M-6.26M-5.99M-21.86M
Net non-operating interest income expense -5,188.24%-1.8M67.69%-745K28.90%-438K66.82%-211K-34K-75.36%-2.31M-616K-636K-1.32M
Non-operating interest expense 3,044.12%1.07M-67.69%745K-28.90%438K-66.82%211K--34K75.36%2.31M--616K--636K--1.32M
Total other finance cost --729K--------------------------------
Other net income (expense) 370.94%4.04M-55,116.84%-52.46M-36,406.15%-23.73M-39,996.92%-26.06M-1.49M-13.10%-95K-65K-65K-84K
Gain on sale of security --4.53M---48.2M---23.73M---24.48M--------------------
Special income (charges) -------3.33M--0---3.33M------0--0--0----
-Less:Restructuring and merger&acquisition ------3.33M--0--3.33M------0--0--0----
Other non- operating income (expenses) 66.64%-497K-871.58%-923K--02,778.46%1.74M---1.49M-13.10%-95K---65K---65K---84K
Income before tax 35.33%-5.38M-210.12%-82.95M-384.07%-33.6M-395.70%-33.18M-8.32M-14.99%-26.75M-6.94M-6.69M-23.26M
Income tax 0.00%7K0.00%7K040.00%7K7K05K
Net income 35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-8.32M-15.00%-26.75M-6.95M-6.69M-23.27M
Net income continuous Operations 35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M---8.32M-15.00%-26.75M---6.95M---6.69M---23.27M
Minority interest income
Net income attributable to the parent company 35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-8.32M-15.00%-26.75M-6.95M-6.69M-23.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-8.32M-15.00%-26.75M-6.95M-6.69M-23.27M
Basic earnings per share 2.06%-0.25-555.62%-5.38-688.33%-1.68-1,108.06%-2.48-0.2553-15.00%-0.8206-0.2131-0.2053-0.7136
Diluted earnings per share 2.06%-0.25-555.62%-5.38-688.33%-1.68-1,108.06%-2.48-0.2553-15.00%-0.8206-0.2131-0.2053-0.7136
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg